Jane D. Englebright - 09 Nov 2021 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP and Chief Nursing Officer
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 09 Nov 2021
Net transactions value: -$839,689
Form type: 4
Filing time: 12 Nov 2021, 16:26:41 UTC
Previous filing: 05 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Sale	$839,689	-3,364	-100%	$249.61	0	09 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.60 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.60 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.